trending Market Intelligence /marketintelligence/en/news-insights/trending/gVgi9PoFnzrMluq8dqdR_w2 content esgSubNav
In This List

Allergan nears $2.47B acquisition of ZELTIQ

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Allergan nears $2.47B acquisition of ZELTIQ

Allergan PLC's $2.47 billion purchase of ZELTIQ Aesthetics Inc. was cleared under U.S. antitrust laws.

The deal's waiting period under the Hart-Scott-Rodino Act expired, bringing the companies closer to completion.

The merger acquisition is still subject to other customer closing conditions.